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Abstract We describe here (1) the heterogeneous expression of
Ca2+-independent transient (A-type) K+ channel K-subunits
(Kv1.4, Kv3.3, Kv3.4, Kv4.2 and Kv4.3) in rat smooth muscle,
heart and brain, (2) the molecular cloning and tissue distribution
of a novel alternatively spliced variant of an A-type K+ channel
K-subunit, Kv4.3, and (3) the functional expression of A-type K+
channels in HEK293 cells by the transfection with the novel
splice variant of Kv4.3. A cDNA encoding this splice variant was
identified from rat vas deferens by RT-PCR cloning. This cDNA
clone contains a 1965 bp open reading frame that encodes for a
protein of 655 amino acids. It has a 19 amino acid insertion in
comparison with Kv4.3 previously reported in rat brain. RT-PCR
analyses showed that the mRNAs of this longer variant are
abundantly expressed in a number of smooth muscles of the rat,
and that the mRNAs of the previously reported clones are absent.
The longer splice variant is very weakly expressed in brain, but is
the major product in heart.
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1. Introduction
A Ca2-independent transient or A-type K current (It or
IA) has been identi¢ed in a wide variety of excitable cells [1].
In nerve, IA reduces the rate of depolarization following an
afterhyperpolarization, and/or contributes to early repolariza-
tion of action potential. IA is thus important in the control of
action potential threshold, frequency and duration [2]. IA has
also been identi¢ed in several smooth muscle cells including
portal vein, ureter, colon, mesenteric artery and vas deferens
[3^6]. Several A-type K channel K-subunits have been cloned
from mammalian brain (e.g. Kv1.4, Kv3.3, Kv3.4, Kv4.1,
Kv4.2 [7,8] and Kv4.3 [9,10]). Recently, on the basis of mo-
lecular biological analyses, it has been suggested that the Kv4
family (Kv4.1, Kv4.2 and/or Kv4.3) contributes to the Ca2-
independent transient outward K current in brain and heart
[11^14]. These results revealed tissue speci¢c distribution of A-
type K channel K-subunits and provided insights into the
molecular basis of these K channels. Although the corre-
sponding macroscopic currents can be separated by electro-
physiological or pharmacological methods, the molecular
identity of IA in smooth muscles has not been reported pre-
viously.
In the present study, we describe diverse distribution of the
A-type K channel K-subunits, Kv1.4, Kv3.3, Kv3.4, Kv4.2
and Kv4.3 in brain, heart and vas deferens. Based on these
RT-PCR results, we suggest that Kv4.2 and Kv4.3 but not
Kv1.4, Kv3.3 or Kv3.4, contribute to IA in vas deferens.
When cDNAs encoding of A-type K channel K-subunits,
Kv4.2 and Kv4.3, were cloned from rat vas deferens, a novel
alternatively spliced variant of Kv4.3 was detected.
2. Materials and methods
2.1. Preparation of RNA and reverse transcription
Total RNAs were extracted from homogenates of brain, heart and
selected smooth muscles of 5^6 week-old male Wistar rat, using the
acid guanidium thiocyanate-phenol method, following digestion with
RNase-free DNase. Reverse transcription (RT) was performed ac-
cording to Gibco BRL’s protocol. Total RNA (2 Wg) and 200 ng of
random hexamer in RNase-free H2O were heated for 10 min at 70‡C
and incubated for 10 min at 25‡C for annealing. This sample was
incubated for 60 min at 42‡C using 150 units of SUPERSCRIPT II
RNase H3 reverse transcriptase (Gibco BRL) in a solution of a ¢nal
volume of 20 Wl which contained 50 mM Tris-HCl (pH 8.3), 40 mM
KCl, 6 mM MgCl2, 1 mM DTT, and 1 mM individual dNTPs. After
this RT procedure, the reaction mixture was added to 80 Wl of distilled
water and was used for PCR.
2.2. Expression of A-type K channels (Kv1.4, Kv3.3, Kv3.4, Kv4.2 and
Kv4.3)
The primer sequences were chosen based on the cDNA of Kv1.4
(rat brain, a GenBank sequence number of X16002), Kv3.3 (rat pheo-
chromocytoma, M84210), Kv3.4 (rat brain, X62841), Kv4.2 (rat
brain, S64320), Kv4.3 (rat brain, U42975), or glyceroaldehyde-3P-
phosphate dehydrogenase (GAPDH) (rat various tissues, X00972).
These included:
Kv1.4 (corresponding to nucleotides 834^1079; 246 bp)
b (+): 5P-GAGAGAAGAGGAGGACAGGGCT-3P,
b (3) : 5P-TGGGGTGCCGAGGTGTCATTCA-3P.
Kv3.3 (corresponding to nucleotides 259^460; 202 bp)
b (+): 5P-GGCGACAGCGGTAAGATCGTG-3P,
b (3) : 5P-GGTAGTAGTTGAGCACGTAGGCGA-3P.
Kv3.4 (corresponding to nucleotides 537^738; 202 bp)
b (+): 5P-CAGGCAGAAGGTGGTAATGGAG-3P,
b (3) : 5P-AGACGATGAGCGGGAGTTGG-3P.
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Kv4.2 (corresponding to nucleotides 163^363; 201 bp)
b (+): 5P-CTCTGCCCACCATGACTGCTA-3P,
b (3) : 5P-CCACTGCATACCTTTCCCCACAA-3P.
Kv4.3 (corresponding to nucleotides 384^653; 270 bp)
b (+): 5P-CTCCCTCAGCTTCCGCCAGACC-3P,
b (3) : 5P-CTGCTGGGTGCCGCGAAGAGTC-3P.
GAPDH (corresponding to nucleotides 532^682; 151 bp)
b (+): 5P-GCCATCACTGCCACTCA-3P,
b (3) : 5P-CAGTGAGCTTCCCGTTC-3P.
The RT reaction product (1 Wl) was ampli¢ed using GeneAmp 2400
(Perkin Elmer) in a total volume of 10 Wl of a solution containing 250
mM dNTPs, 2 mM MgCl2, 10 mM Tris-HCl (pH 8.8), 50 mM KCl,
100 ng (Kv1.4, Kv3.3, Kv3.4, Kv4.2 and Kv4.3) or 25 ng (GAPDH)
sense and antisense primers, and 0.25 unit Taq DNA polymerase
(Takara). The thermal cycler program used for PCR ampli¢cation
included: a 0.5 min denaturation step at 94‡C, a 0.5 min annealing
step at 55‡C, and a 0.5 min primer extension step at 72‡C. The am-
pli¢cation was performed for 32 cycles. Thereafter, reaction mixtures
were heated at 72‡C for 7 min. Ampli¢ed products were separated on
8 M urea-denatured 5% polyacrylamide gels in Tris-borate/EDTA
bu¡er at 300 V for 90 min, visualized with 1 Wg/ml ethidium bromide
and documented on FAS 1000 (TOYOBO).
2.3. PCR cloning of the Kv4.2 and Kv4.3 cDNA and DNA sequencing
Oligonucleotide primers were arranged as follows: Kv4.2 (+):
5P-CCACGAATTCCCTGTGAGCCGTGTTCCCCAGTG-3P corre-
sponding to nucleotides 118^97 and (3) : 5P-CACCCTCGAGATT-
CTTTCCATAGTCAGGGCTC-3P corresponding to nucleotides
1942^1922 of rat brain Kv4.2. Kv4.3 (+): 5P-CCACGAATTC-
CTGGTGCGTAGTGTATGAGCA-3P corresponding to nucleotides
48^29 and (3) : 5P-TAGGTCTAGAGTGGCCACCCACCAACA-
TAC-3P corresponding to nucleotides 1981^1962 of rat brain Kv4.3.
The sequences in italic are EcoRI (GAATTC), XhoI (CTCGAG) and
XbaI (TCTAGA) recognition sites which were added to the insert
PCR products into vector plasmid DNA, pBluescript SK (Strata-
gene) in the proper orientation. The thermal cycler program used
for PCR ampli¢cation included a 0.5 min denaturation step at
94‡C, a 0.5 min annealing step at 55‡C and a 2 min primer extension
step at 72‡C for 40 cycles. In PCR cloning experiments, AmpliTaq
Gold (Perkin Elmer) was used as a Taq DNA polymerase. Reaction
products were separated on 1% agarose gels in Tris-acetate/EDTA
bu¡er and were recovered from gel fragments using GENECLEAN
II (Funakoshi). Following this, the cDNAs were ligated into EcoRI/
XhoI or EcoRI/XbaI recognition sites of pBluescript SK, respec-
tively. Cloned cDNAs were sequenced by dideoxy methods using
Thermo Sequenase Cycle Sequencing Kit, with DSQ-1000L machine
(Shimadzu).
2.4. Cell culture, transfection and electrophysiology
Human embryonal kidney cell line (HEK293) was obtained from
Health Science Research Resources Bank (HSRRB) and maintained
in Minimum Essential Medium (Gibco BRL) supplemented with 10%
heat-inactivated fetal calf serum, penicillin (100 units/ml), streptomy-
cin (100 Wg/ml). A mammalian expression vector, pcDNA3.1 (Invitro-
gen), was used for stable transfection of HEK239 cells with Kv4.3 by
calcium phosphate precipitation and then G418 (Gibco BRL) resist-
ance cells were selected as previously described [15] and identi¢ed by
Northern blot hybridization.
Electrical recordings of A-type K current were obtained from non-
transfected or Kv4.3-transfected HEK293 cells using whole-cell volt-
age-clamp techniques at room temperature (23 þ 1‡C). CEZ-2200 (Ni-
hon Kohden) ampli¢er was used. The resistance of the recording
pipettes ranged from 1^3 m6. The series resistance was partly com-
pensated electrically under whole-cell clamp. Data were stored and
analyzed in a computer using software, AQ and Cellsoft, which
were developed in University of Calgary, Canada. Leakage currents
at potentials positive to 380 mV were subtracted on the computer
assuming a linear relationship between current and voltage in the
range of 3120 and 380 mV. The pipette ¢lling solution had the
following composition (mM): 140 KCl, 4 MgCl2, 5 Na2ATP, 0.05
EGTA, and 10 HEPES. The pH was adjusted to 7.2 with KOH.
The external solution had the following composition (mM): 137
NaCl, 5.9 KCl, 2.2 CaCl2, 1.2 MgCl2, 14 glucose, and 10 HEPES.
The pH was adjusted to 7.4 with NaOH.
2.5. Determination of Kv4.3 splice variant mRNA levels
Total RNA extraction, RT and PCR reactions were performed as
described above. PCR oligonucleotide primers for three splice variants
of Kv4.3 were designed, as follows. For Kv4.3S (see Section 3), (+):
5P-AGCACCATCCACATCCAG-3P corresponding to nucleotides
1663^1680 and (3) : 5P-GTGTTGGGTTCGTGGAGA-3P corre-
sponding to nucleotides 1941^1924 of rat hippocampus Kv4.3
cDNA (a GenBank sequence number of L48619) [16]. For Kv4.3M
and Kv4.3L, on the basis of 19 amino acid insertion at C-terminal
intracellular region, the primers consist of: (+): 5P-GGCACCCCA-
GAAGAGGAGCA-3P corresponding to nucleotides 1372^1391 and
(3) : 5P-AGCAGCAGGTGGTGGTGAGG-3P corresponding to nu-
cleotides 1642^1623 of rat brain Kv4.3 cDNA (U42975). The thermal
cycler program used for PCR ampli¢cation included: a 0.5 min de-
naturation step at 94‡C, a 0.5 min annealing step at 60‡C and a 0.5
min primer extension step at 72‡C for 40 or 30 cycles. Ampli¢ed
products were separated on 8 M urea-denatured 5% polyacrylamide
gels, visualized with 1 Wg/ml ethidium bromide and documented on
FAS 1000. Relative band intensities were quanti¢ed by densitometric
scanning of the negatives using PDI densitometer (Quantity One).
3. Results
3.1. Diverse distribution of A-type K+ channel K-subunits
The mRNA species responsible for the A-type K channel
K-subunits, namely Kv1.4, Kv3.3, Kv3.4, Kv4.2 and Kv4.3,
were quantitated using ethidium bromide-stained gels of RT-
PCR products. The speci¢city of each ampli¢ed product was
established from the size of the fragment stained with ethidi-
um bromide and con¢rmed by sequencing analyses. GAPDH
mRNA was used to provide a basis for the comparison of
these ¢ve mRNA samples (Kv1.4, Kv3.3, Kv3.4, Kv4.2 and
Kv4.3), which are candidates for A-type K channels. The
cycle numbers used for ampli¢cation, and the amount of
each primer were carefully adjusted to avoid saturation during
ampli¢cation. A linear relationship between the cycle number
and the band density was observed between 26 and 40 cycles.
Furthermore, a linear relationship between the amount of
total RNA and band density was observed within the range
of 0.1 to 10 Wg of total RNA, suggesting that RT-PCR e⁄-
cacy is constant under these conditions. For each type of
RNA, 246 bp (Kv1.4), 201 bp (Kv4.2), 270 bp (Kv4.3), 151
bp (GAPDH) fragments were easily identi¢ed by ethidium
bromide staining after a 32 cycle PCR, respectively.
Based on these RT-PCR results, a heterogenous distribu-
tion of A-type K channel K-subunits was identi¢ed in brain,
heart and vas deferens (Fig. 1). Although Kv4.2 and Kv4.3
mRNAs were detected in all three tissues, Kv1.4 mRNA could
not be detected in vas deferens (Fig. 1A; n = 6). Furthermore,
both Kv3.3 and Kv3.4 mRNAs were expressed at a relatively
high level in brain but were undetectable in heart and vas
deferens (Fig. 1B). The amount of Kv4.2 mRNA relative to
that of GAPDH was 12.6 þ 1.4, 9.3 þ 1.0 and 9.4 þ 0.4%
(n = 6) in brain, heart and vas deferens, respectively. The rel-
ative amount of Kv4.3 mRNA was 43.5 þ 2.0, 8.9 þ 0.4 and
51.0 þ 2.6% (n = 6) in brain, heart and vas deferens, respec-
tively.
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3.2. RT-PCR based cloning of Kv4.2 and Kv4.3 in rat vas
deferens
Full length Kv4.2 and Kv4.3 clones from vas deferens were
PCR ampli¢ed with speci¢c primers for each of these K
channel isoforms (see Section 2). Lanes 1 and 2 in Fig. 2
show a representative pattern from 1.8% agarose gel electro-
phoresis of PCR products for Kv4.2 and Kv4.3 mRNA in vas
deferens. Ampli¢ed products of approximately 2060 bp
(Kv4.2) and 2030 bp (Kv4.3) were identi¢ed by ethidium bro-
mide staining. Each ampli¢ed product was digested with
EcoRI/XhoI (Kv4.2) or EcoRI/XbaI (Kv4.3) and was ligated
into EcoRI/XhoI or EcoRI/XbaI double-digested site of pBlue-
script SKU+, which were termed pBS-Kv4.2 and pBS-Kv4.3,
respectively. The fragments arising from HindIII/KpnI cleav-
age of pBS-Kv4.2 gave four bands (approximately 350, 800,
850 and 2950 bp) (data not shown) with the predicted sizes for
brain Kv4.2 previously reported [8]. The fragments arising
from EcoRI/BamHI cleavage of pBS-Kv4.3 gave two bands
(approximately 1000 bp and 4000 bp) with the predicted sizes
for brain Kv4.3 [9]. In contrast, the fragments arising from
BamHI/XbaI cleavage of pBS-Kv4.3 gave two bands (approx-
imately 1000 and 4000 bp) (lane 4), which are di¡erent from
the predicted sizes (approximately 950 and 4000 bp). Subse-
quently, rat brain Kv4.3 was cloned using RT-PCR. The re-
sultant pBS brain Kv4.3 was digested with BamHI/XbaI, giv-
ing two bands (approximately 950 and 4000 bp) with the
predicted sizes (lane 3). These results suggest that a novel
splice variant of Kv4.3 may be expressed in vas deferens.
Nucleotide sequences were determined using dideoxynucleo-
tide chain termination (see Section 2). The sequence of Kv4.2
in vas deferens (vKv4.2) is nearly identical to rat Shal 1 (brain
Kv4.2) reported by Baldwin et al. [7], with the exception of
one amino acid substitution at residue 537 (Ser-Thr). As re-
ported [7], the amino acid sequences of Shal 1 and Kv4.2 from
brain are virtually identical at both the nucleotide and amino
acid levels, except for a distinct C-terminus of RK5 (heart
Kv4.2) cloned by Roberds et al. [8]. Therefore, RT-PCRs
and successive subcloning of Kv4.2 from rat heart and brain
cDNA were performed again. The results obtained from 10
independent experiments revealed that both brain and heart
Kv4.2 nucleotide sequences are identical to vKv4.2.
As predicted from restriction enzyme mapping (Fig. 2), a
splice variant of Kv4.3, which has the insertion of 57 bp in the
intracellular C-terminal region, was detected in vas deferens.
This region was termed the ‘splicing box’. The deduced amino
acid sequence of the intracellular C-terminal region in the
splice variants of Kv4.3 is shown in Fig. 3. The ‘splicing
box’ contains 19 amino acids, GLSYLVDDPLLSVRTSTIK
(residue: 488^506); more than half of which are non-charged
residues, and have relatively high hydrophobicity. Database
searches (GenBank and SWISS-PROT) yielded no signi¢cant
homology for this ‘splicing box’ region with the known other
sequences, at either the nucleotide or the amino acid levels.
Computer analysis of this clone (GENETYX-MAC) suggests
that the ‘splicing box’ may have a site for protein kinase
phosphorylation; speci¢cally that this splice variant of
Kv4.3 in vas deferens has a C-terminal domain with addition-
al potential sites for phosphorylation by protein kinase C
(Fig. 3).
Recently, another splice variant of Kv4.3, with an open
reading frame of 611 amino acids (Kv4.3S) has been isolated
from rat hippocampus [16]. The nucleotide sequences are di-
vergent in C-terminus, resulting in a frame shift in the pre-
dicted coding sequence. Moreover, in this splice variant, the
‘splicing box’ is apparently not present. Therefore, speci¢c
oligonucleotide primers for Kv4.3S on the basis of C-terminal
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Fig. 1. Diverse distribution of A-type K channel K-subunits
(Kv1.4, Kv3.3, Kv3.4, Kv4.2 and Kv4.3) mRNAs identi¢ed by RT-
PCR. A: RT-PCRs were performed with four pair primers (Kv1.4,
Kv4.2, Kv4.3 and GAPDH) for 32 cycles (see Section 2). B: RT-
PCRs were performed with three pair primers (Kv3.3, Kv3.4 and
GAPDH) for 32 cycles. cDNA was obtained by reverse transcrip-
tion of the total RNAs extracted from rat brain (lane 1), heart
(lane 2) and vas deferens (lane 3), respectively. Ampli¢ed products
were separated on 8 M urea-denatured 5% polyacrylamide gels and
analyzed by ethidium bromide staining. 246 bp (Kv1.4), 202 bp
(Kv3.3), 202 bp (Kv3.4), 201 bp (Kv4.2), 270 bp (Kv4.3) and 151
bp (GAPDH) fragments were identi¢ed by ethidium bromide stain-
ing, respectively.
Fig. 2. Analysis of ampli¢ed products by 1.8% agarose gel electro-
phoresis. Lane 1: PCR products from vas deferens for Kv4.2. Lane
2: PCR products for Kv4.3 mRNA. Lane 3: pBS brain Kv4.3 was
digested with BamHI/XbaI, giving two bands (approximately 950
and 4000 bp) with the predicted sizes. Lane 4: the fragments arising
from BamHI/XbaI cleavage of pBS-Kv4.3 yielded two bands (ap-
proximately 1000 and 4000 bp), which are di¡erent from the pre-
dicted sizes (approximately 950 and 4000 bp). The migration of the
size marker (PX 174/Hinc II) is shown on the right.
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intracellular region were designed and RT-PCR was per-
formed using brain, heart and vas deferens cDNA, respec-
tively. Ampli¢ed products were separated on 8 M urea-dena-
tured 5% polyacrylamide gels and visualized with ethidium
bromide. RT-PCR analyses by 40 cycle ampli¢cation showed
that the mRNAs of this splice variant (Kv4.3S) were strongly
expressed in rat brain, but only weakly in heart. In vas def-
erens, no detectable signal was observed (Fig. 4).
3.3. Tissue distribution of mRNA expression encoding Kv4.3
splice variants
PCR oligonucleotide primers were targeted to identify the
‘splicing box’ in the C-terminal intracellular region. RT-PCR
on the total RNA from rat brain, heart and selected smooth
muscles gave 214, 271 and 301 bp products, respectively (Fig.
5A) which were subcloned and sequenced. The products 214
and 271 bp corresponded to the equivalent regions of the
splice variants of Kv4.3: these were termed Kv4.3M (214
bp) and Kv4.3L (271 bp), respectively. On the other hand,
301 bp products consisted of non-speci¢c sequence. These
two splice variants (Kv4.3M and Kv4.3L) were expressed in
di¡erent levels in brain, heart and smooth muscle tissues. Fig.
5A demonstrates that, unlike brain and heart, only Kv4.3L is
expressed in smooth muscle tissues. Furthermore, the same
analyses were performed in kidney, liver, lung, skeletal muscle
(phrenicopleural fascia), spleen and pancreas. Interestingly,
Kv4.3L was expressed abundantly in kidney, and Kv4.3M
alone in skeletal muscle and pancreas. In lover, lung and
spleen, both variants were weakly expressed (Fig. 5B).
To analyze the relationship between the band density and
the amounts of ampli¢ed product, each product was diluted in
a selected range and separated using 8 M urea-denatured 5%
polyacrylamide gels with several lanes demonstrating the
chosen dilutions. Densitometric scanning of bands yielded a
linear relationship between the band density, and the log of
the amount after the dilution (data not shown). Based on this
result, we calculated the amount of the ampli¢ed product
from the band density. The ratio of Kv4.3M and Kv4.3L
could then be determined in brain, heart and vas deferens.
Although both splice variants were expressed in brain and
heart, note that Kv4.3L mRNA is very weakly expressed in
brain but is the major product in heart (3.9 þ 1.2% and
89.2 þ 2.8%, respectively) (Fig. 5C). It is important to note
that only Kv4.3L mRNA was detected in vas deferens and
in the other smooth muscles which were examined (aorta,
colon, stomach, urinary bladder; Fig. 5A).
3.4. Functional expression of Kv4.3L in HEK239 cells
To examine whether Kv4.3L cDNA encodes A-type K
channel, Kv4.3L was expressed in HEK293 cells. Fig. 6A
shows typical recordings of membrane currents elicited by
depolarization from 380 mV by 10 mV step. Transient out-
ward currents were observed at potentials positive to 340 mV
(Fig. 6B). The current reached the peak within 10 ms and
decayed to a steady level within 250 ms at +40 mV. The
averaged peak amplitude of the current at +40 mV was
4.21 þ 1.22 nA (n = 5). On the other hand, in non-transfected
FEBS 19631 17-12-97
Fig. 3. Alignment of the amino acid sequences of alternatively splice variants of Kv4.3 in intracellular C-terminal regions. The amino acid se-
quences corresponding to four variants of Drosophila Shal (dShal) and Kv4.3 from rat brain (Kv4.3M and Kv4.3S) and vas deferens (Kv4.3L)
were aligned. The sequences, Kv4.3M, Kv4.3S and dShal have been reported previously by Serodio et al. (1996) [10], Tsaur et al. (1997) [15]
and Wei et al. (1990) [32], respectively. Dashes indicate gaps introduced into the sequence to improve alignment. Dots indicate the sequences
identical to Kv4.3L. Putative protein kinase C phosphorylation sites are identi¢ed by closed circles. The insertion residues, by alternative splic-
ing, are denoted by the boxed region.
Fig. 4. Expression of a splice variant of Kv4.3S isolated from rat
hippocampus [15] with an open reading frame of 611 amino acids.
RT-PCRs were performed with a speci¢c degenerate PCR primer
for 40 cycles. cDNA was obtained by reverse transcription of the
total RNAs extracted from rat brain (lane 1), heart (lane 2) and vas
deferens (lane 3), respectively. Ampli¢ed products were separated on
8 M urea-denatured 5% polyacrylamide gels. As an internal stand-
ard, GAPDH cDNA was ampli¢ed for 30 cycles (bottom panel).
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cells, more slowly activated and non-inactivated outward cur-
rents were elicited by depolarization. The averaged amplitude
of outward current at +40 mV was 0.22 þ 0.04 nA (n = 3) in
non-transfected cells. When 2 mM 4-aminopyridine (4-AP)
was applied, the transient outward current activated at +20
mV in a transfected cell was markedly reduced (Fig. 6B,
27.9 þ 2.1% of the control). Similar decrease in the peak out-
ward current by 2 mM 4-AP was observed at any potentials
positive to 330 mV (Fig. 6C). These results indicate that A-
type K channels sensitive to 4-AP were functionally ex-
pressed in HEK293 cells transfected with Kv4.3L.
4. Discussion
4.1. Main ¢ndings
Our RT-PCR analyses show that, of the K channel iso-
forms (Kv1.4, Kv3.3, Kv3.4, Kv4.2 and Kv4.3) which are
thought to be responsible for IA in other tissues [11^14], the
mRNA of Kv4.3 is predominant in vas deferens smooth
muscle. Moreover, a newly identi¢ed splice variant of Kv4.3
is predominant in both cardiac and smooth muscles but is not
strongly expressed in brain. In vas deferens, the expression
level of Kv4.2 mRNA was only 18% of that of Kv4.3; and
Kv1.4, Kv3.3 and Kv3.4 mRNAs were almost undetected. In
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Fig. 5. Tissue distribution of the two splice variants of Kv4.3 by
RT-PCR. A: PCR oligonucleotide primers were targeted to identify
speci¢c ‘splicing box’ in C-terminal intracellular region. Ampli¢ed
products were separated on 8 M urea-denatured 5% polyacrylamide
gels, visualized with 1 Wg/ml ethidium bromide and quanti¢ed by
scanning pictures using a PDI densitometer. The sizes of the two
PCR products are 214 and 271 bp, respectively. As an internal
standard, GAPDH cDNA was also ampli¢ed (bottom panel). Lane
1: brain; lane 2: heart; lane 3: vas deferens; lane 4: aorta; lane 5:
colon; lane 6: stomach; lane 7: urinary bladder. B: Tissue distribu-
tion of the two splice variants was analyzed as described in A. Lane
1: brain; lane 2: kidney; lane 3: liver; lane 4: lung; lane 5: skeletal
muscle; lane 6: spleen; lane 7: pancreas. C: Data obtained from
separate six experiments in A are summarized. The band densities
of ampli¢ed fragments were normalized to those of GAPDH, and
the relative expression of the splice variants in brain, heart and vas
deferens was calculated.
Fig. 6. Membrane currents in HEK293 cells transfected with Kv4.3.
A: A transfected cell was depolarized for 1 s from the holding po-
tential of 380 mV to various potentials in a range of 370 and +40
mV by 10 mV set at an interval of 10 s. Transient outward currents
were observed at potentials positive to 340 mV. B: Application of
2 mM 4-aminopyridine (4-AP) markedly reduced the transient out-
ward current which was elicited by depolarization from 380 to +20
mV. C: The current-voltage relationships of peak outward current
in the absence (a) and presence of 2 mM 4-AP (b). The amplitude
at +40 mV was taken as the unity (1.0) in each cell. Each symbol
indicates the mean value obtained from 5 cells. The S.E. of the
mean was included in the symbols. The averaged peak amplitude at
+40 mV was 4.21 þ 1.22 nA and 1.60 þ 0.47 nA in the absence and
presence of 4-AP, respectively. The di¡erence is statistically signi¢-
cant when compared with using Student’s t-test (P6 0.01).
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heart, as expected from previous reports [9,12], the Kv1.4,
Kv4.2 and Kv4.3 mRNAs were present at similar levels.
4-Aminopyridine (4-AP) is used to block IA in many tissues,
including smooth muscles. The Kv3 family of K currents are
blocked by 4-AP at millimolar concentrations but are also
inhibited by relatively low concentrations (6 5 mM) of exter-
nally applied tetraethylammonium (TEA). IA like currents in
cardiac and smooth muscles are not blocked by 10 mM TEA
[17,18]. Our ¢ndings that Kv3.3 and Kv3.4 mRNAs are ab-
sent in heart and vas deferens are, therefore, consistent with
this electrophysiological pro¢le.
Although Kv4.2 in rat vas deferens is identical to brain
Kv4.2, we identi¢ed a novel splice variant of Kv4.3 in vas
deferens. It includes an insertion of 57 bp (19 amino acids)
in the intracellular C-terminal region (Kv4.3L). The electro-
physiological results obtained from HEK293 cells transfected
with Kv4.3L clearly showed that Kv4.3L cDNA encodes
functional A-type K channel which is sensitive to 4-AP. In-
terestingly, there are large tissue di¡erences in mRNA expres-
sion of three splice variants of Kv4.3 (S, M and L). In smooth
and cardiac muscles, Kv4.3L was predominant and the other
two variants were virtually absent. In brain, Kv4.3M mRNA
was most abundant, although the other two variants were also
present at lower levels. It will be interesting to determine
whether di¡erences in electrophysiological characteristics can
be attributed to these three types of Kv4.3 splice variants.
Protein phosphorylation is a key regulatory mechanism of
membrane excitability and ion channel function [19]. The
fact that the additional 19 amino acid residues in C-terminal
region of Kv4.3L include PKC phosphorylation sites may be
important in the regulation of the K channels encoded by
these splice variants.
4.2. Functional roles of Kv4.3 in smooth muscle cells
Since the resting membrane potential is between 350 and
360 mV in most types of smooth muscles, more than half of
IA channels are inactivated even at rest [3^6]. The major func-
tion of IA in smooth muscle cells is, therefore, regulation of
action potential threshold and ¢ring frequency immediately
following hyperpolarization, during which a substantial pop-
ulation of IA channels recovers from inactivation [4]. In con-
trast, in cardiac myocytes, activation of the Ca2-independent
transient outward K current (It) contributes to early phase
of action potential repolarization [20]. Kv4.2 and Kv4.3 have
been shown to contribute to It in rat cardiac myocytes, based
on antisense mRNA methods combined with electrophysio-
logical analyses [14].
We have reported that IA in smooth muscle cells can be
blocked by low concentration of arachidonic acid (AA) [6]
and that It in rabbit atrium is far less sensitive to AA than
IA in rabbit vas deferens [6]. Recently, it has also been shown
that AA blocks Kv4 family K channels rather than Kv1,
Kv2 and Kv3 families [21]. These ¢ndings, in combination
with the present results, suggest that IA in some smooth
muscles may mainly be attributable to Kv4.3. The reason
why the sensitivity of IA in ventricular myocytes to AA is
much lower than that in smooth muscle is not completely
clear in this study. In ventricular myocytes, however, the ex-
pression of Kv1.2, Kv1.4, Kv1.5 and Kv2.1 mRNAs are
abundant and these themselves or combination with L-subunit
may be factors which contribute to IA [22]. The lower sensi-
tivity of these K-subunits to AA [21] could explain the di¡er-
ence between ventricular and smooth muscle cells.
4.3. Diversity of K+ channels responsible for IA
Understanding the diversity of A-type K channels in var-
ious tissues is an essential prerequisite to determination of the
physiological and/or pharmacological characteristics of these
channels and identi¢cation of their regulation mechanisms,
such as the sensitivity to PKC activators [19], AA [6,23,24]
or some K channel blockers [25]. Kv1.4 and Kv4.2 are di¡er-
entially expressed in rat central neurons, and this pattern of
distribution implies distinct roles for these K channel pro-
teins in vivo [26]. Kv4.2 and Kv4.3 have many similarities in
structure, and electrophysiological properties ; and in some
tissues, their subcellular localization is similar. However, these
two isoforms have also been suggested to have separate func-
tional roles in neurons which co-express them [16].
Heterotetrametric channel structure, usually involving dif-
ferent Kv families has been suggested as a means of generat-
ing channel diversity [27,28]. When hybrid channels consisting
of Kv1.4 and other Kv1 family K-subunits are expressed in
Xenopus oocytes, they exhibit kinetics that more closely re-
semble a native cardiac It [29]. However, since Kv1.4 is absent
in vas deferens, it is unlikely that heterotetrametric channels
of Kv1 family are mainly responsible for IA in this tissue.
In addition, channel heterogeneity resulting from alterna-
tive splicing of K-subunit has been described [30]. N- and C-
terminal are known to play important roles for the formation
of homo- and heteromultimers [31,32]. Heteromeric channel
complexes consisting of two di¡erent splice variants can alter
the kinetics of channel re-activation. Indeed, Drosophila Shal
has much shorter sequences in C-terminal region than rat
Kv4.3M and physiologically signi¢cant di¡erences in kinetics
observed in the currents expressed in Xenopus oocytes [10,33].
However, this mechanism appears not to be important in vas
deferens smooth muscles, since expression level of Kv4.3L was
much higher than those of other variants.
It has been reported that pore-forming K-subunits of some
delayed recti¢er K channels are converted to A-type K
channels by association with peripheral L-subunit [29,34,35].
The possibility that this type of channel complex contributes
to IA in smooth muscle cells can not be ruled out.
In summary, we have identi¢ed a heterogeneous pattern of
expression of Kv1.4, Kv3.3, Kv3.4, Kv4.2 and Kv4.3 mRNA,
and a novel splice variant mRNAs of Kv4.3 in brain, heart
and vas deferens. The novel splice variant of Kv4.3 has an
additional 19 amino acid residue in cytosolic region near C-
terminus, and the corresponding mRNA is predominant in
both cardiac and smooth muscles, providing indirect evidence
that Kv4.3 contributes to IA in some smooth muscles. It seems
likely that Kv4.3L is probably the K channel responsible for
IA in smooth muscle cells and in cardiac myocytes, even
though the functional roles of IA and It in these two types
of muscles are not similar.
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